HDAC inhibitors: Much to learn about effective therapy - The Shabason/Tofilon/Camphausen article reviewed [HDAC inhibitors in cancer care] Journal Article
| Author: | Marks, P. A. |
| Article Title: | HDAC inhibitors: Much to learn about effective therapy - The Shabason/Tofilon/Camphausen article reviewed [HDAC inhibitors in cancer care] |
| Keywords: | cancer chemotherapy; treatment response; unclassified drug; histone deacetylase inhibitor; clinical trial; solid tumor; drug approval; note; cancer radiotherapy; protein function; cell proliferation; cell death; enzyme inhibition; protein targeting; antineoplastic activity; angiogenesis; gene expression regulation; cutaneous t cell lymphoma; hematologic malignancy; immune response; vorinostat; cell migration; genetic disorder; drug sensitivity; romidepsin; histone deacetylase 1; histone deacetylase 4; histone deacetylase 5; histone deacetylase 6; histone deacetylase 7; istodax |
| Journal Title: | Oncology (Norwalk) |
| Volume: | 24 |
| Issue: | 2 |
| ISSN: | 0890-9091 |
| Publisher: | C M P Medica LLC * The Oncology Group |
| Date Published: | 2010-02-01 |
| Start Page: | 185 |
| End Page: | 188 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 20361470 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 20 April 2011" - "CODEN: OCLGE" - "Source: Scopus" |
